Michael Miller v. HHS - Influenza, myasthenia gravis and Guillain-Barré Syndrome (2017)
Case summary [AI summaries can sometimes make mistakes]
Michael Miller filed a petition on May 27, 2016, alleging that the influenza vaccine he received on or about September 21, 2015, caused him to suffer from myasthenia gravis (MG) and Guillain-Barré Syndrome (GBS), with residual effects lasting more than six months. The influenza vaccine is listed on the Vaccine Injury Table.
The respondent denied that the flu vaccine caused Mr. Miller's conditions.
However, the parties reached a stipulation for compensation, which Special Master Christian J. Moran adopted as the decision of the Court.
The stipulation awarded Mr. Miller a lump sum payment of $336,326.42, intended to compensate for all damages available under the program.
Judgment was to be entered according to this decision and the stipulation. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses.
Petitioner counsel was Leah V. Durant, and respondent counsel was Christine M.
Becer.
Theory of causation
Petitioner Michael Miller received an influenza vaccine on or about September 21, 2015. He alleged this vaccine caused him to develop myasthenia gravis (MG) and Guillain-Barré Syndrome (GBS), with residual effects lasting more than six months. The influenza vaccine is listed on the Vaccine Injury Table. Respondent denied causation. The parties entered into a stipulation for compensation, which Special Master Christian J. Moran adopted. The stipulation resulted in a lump sum award of $336,326.42. The public text does not detail the specific mechanism of injury, expert testimony, or clinical findings. Petitioner was represented by Leah V. Durant, and respondent by Christine M. Becer. The decision date was May 12, 2017.
Source PDFs
USCOURTS-cofc-1_16-vv-00637